PBLA - Panbela Therapeutics, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 0.0201

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.00 - $ 0.47

Volume

9,950

Average Volume

Market Cap

284,587

Beta (5Y Monthly)

$ -0.79

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-14-2024	09-30-2024	10-Q
2	08-13-2024	06-30-2024	10-Q
3	05-15-2024	03-31-2024	10-Q
4	03-26-2024	12-31-2023	10-K
5	11-09-2023	09-30-2023	10-Q
6	08-10-2023	06-30-2023	10-Q
7	05-04-2023	03-31-2023	10-Q
8	03-16-2023	12-31-2022	10-K
9	11-10-2022	09-30-2022	10-Q
10	08-15-2022	06-30-2022	10-Q
11	05-12-2022	03-31-2022	10-Q
12	03-24-2022	12-31-2021	10-K
13	11-10-2021	09-30-2021	10-Q
14	08-11-2021	06-30-2021	10-Q
15	05-12-2021	03-31-2021	10-Q
16	03-25-2021	12-31-2020	10-K
17	11-12-2020	09-30-2020	10-Q
18	08-11-2020	06-30-2020	10-Q
19	05-12-2020	03-31-2020	10-Q
20	03-24-2020	12-31-2019	10-K
21	11-13-2019	09-30-2019	10-Q
22	08-13-2019	06-30-2019	10-Q
23	05-14-2019	03-31-2019	10-Q
24	03-22-2019	12-31-2018	10-K
25	11-05-2018	09-30-2018	10-Q
26	08-13-2018	06-30-2018	10-Q
27	05-14-2018	03-31-2018	10-Q
28	03-21-2018	12-31-2017	10-K
29	11-14-2017	09-30-2017	10-Q
30	08-10-2017	06-30-2017	10-Q
31	05-11-2017	03-31-2017	10-Q
32	03-30-2017	12-31-2016	10-K
33	11-10-2016	09-30-2016	10-Q
34	08-11-2016	06-30-2016	10-Q
35	05-12-2016	03-31-2016	10-Q
36	03-08-2016	12-31-2015	10-K
37	11-16-2015	09-30-2015	10-Q
38	08-13-2015	06-30-2015	10-Q
39	05-15-2015	03-31-2015	10-Q
40	03-30-2015	12-31-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Panbela Therapeutics Q3 EPS $(1.48) Up Fro...
11/14/2024 21:20:33

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(1.48) per share. This is a 97.25 percent increase over losses...

HC Wainwright & Co. Reiterates Neutral on ...
08/15/2024 10:15:37

HC Wainwright & Co. analyst Joseph Pantginis reiterates Panbela Therapeutics (OTC:PBLA) with a Neutral.

HC Wainwright & Co. Reiterates Neutral on ...
06/24/2024 17:06:14

HC Wainwright & Co. analyst Joseph Pantginis reiterates Panbela Therapeutics (OTC:PBLA) with a Neutral.

HC Wainwright & Co. Downgrades Panbela The...
05/16/2024 17:31:26

HC Wainwright & Co. analyst Joseph Pantginis downgrades Panbela Therapeutics (OTC:PBLA) from Buy to Neutral.

Panbela Therapeutics Q1 2024 GAAP EPS $(2....
05/15/2024 20:21:34

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(2.28) per share which missed the analyst consensus estimate o...

HC Wainwright & Co. Maintains Buy on Panbe...
04/02/2024 12:49:44

HC Wainwright & Co. analyst Joseph Pantginis maintains Panbela Therapeutics (OTC:PBLA) with a Buy and lowers the price t...

Roth MKM Maintains Buy on Panbela Therapeu...
03/27/2024 15:59:18

Roth MKM analyst Jonathan Aschoff maintains Panbela Therapeutics (OTC:PBLA) with a Buy and maintains $25 price target.

Recap: Panbela Therapeutics Q4 Earnings
03/26/2024 20:55:05

Panbela Therapeutics Q4 2023 GAAP EPS $(65...
03/26/2024 20:51:48

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(65.90) per share which missed the analyst consensus estimate ...

Earnings Preview: Panbela Therapeutics
03/25/2024 15:01:06

top-4-health-care-stocks-that-are-preparing-to-pump-this-month

Top 4 Health Care Stocks That Are Preparin...
02/23/2024 12:50:29

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Panbela Regains Nasdaq Compliance
02/15/2024 13:05:07

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
02/14/2024 21:31:06

Watching Panbela Therapeutics; Roth MKM Sa...
02/14/2024 19:52:04

Roth MKM Maintains Buy on Panbela Therapeu...
02/05/2024 19:12:26

Roth MKM analyst Jonathan Aschoff maintains Panbela Therapeutics (NASDAQ:PBLA) with a Buy, adjusts target to $25 from $500.

whats-going-on-with-panbela-therapeutics-stock-today

What's Going On With Panbela Therapeutics ...
01/30/2024 14:56:02

Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expe...

Panbela Therapeutics Announced Abstract Fo...
01/30/2024 13:18:14

Poster PresentationTitle: Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovari...

Crude Oil Down Over 1%; Science 37 Holding...
01/29/2024 19:24:02

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. Th...

why-panbela-therapeutics-shares-are-trading-lower-by-65-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Panbela Therapeutics Shares Are Tradin...
01/29/2024 19:09:05

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
01/29/2024 17:31:07